Neuropsychological Evaluation Report (Dementia/MCI-Focused)

Patient Name: [Patient full name] MRN: [Medical record number] DOB: [Date of birth] Age at Testing: [Age in years]

Evaluation Type: [outpatient / inpatient]; [in-person / telehealth]; [Primary language(s) used]

Referral Source: [Referring clinician name, degree, specialty]

Examiner: [Name, degree, credentials, license number]

Dates: Clinical Interview: [date] | Testing: [date(s)] | Report Completion: [date]

(Omit any header fields that are not available rather than leaving blank.)

Impressions and Staging

Cognitive Stage: [Cognitively Normal / Subjective Cognitive Decline / Mild Cognitive Impairment (amnestic single-domain / amnestic multi-domain / non-amnestic single-domain / non-amnestic multi-domain) / Major Neurocognitive Disorder (mild / moderate / severe)] (Base severity for Major Neurocognitive Disorder on level of functional dependence. If informant data is absent, explicitly state reduced confidence in staging.)

Most Likely Etiology: [Suspected primary etiology] (Use probabilistic language such as "most consistent with" and link to salient clinical features and test pattern.)

Key Differential Considerations: [Alternative diagnoses and rationale] (List alternatives considered with features for and against; note mixed pathology if applicable.)

Confidence and Constraints: [Overall interpretive confidence and key limitations] (Explicitly state if limited by absent informant, validity concerns, or norm mismatch.)

Key Recommendations

1. [Immediate safety action]: [What to do] — Who: [Responsible party] — Rationale: [Link to specific findings] (Prioritize driving, medication management, financial protections, supervision needs at top of list.)
2. [Medical follow-up]: [Action] — Who: [Responsible clinician or service] — Rationale: [Finding-based justification]
3. [Functional support]: [Action such as pillbox, automated reminders, OT/SLP referral] — Who: [Responsible party] — Rationale: [Link to cognitive deficits]
4. [Caregiver support]: [Education, resources, support groups] — Who: [Responsible party] — Rationale: [Link to caregiver strain or safety needs]
5. [Follow-up interval]: [Timeframe] — Earlier reassessment triggers: [Safety events, rapid decline, new psychosis, stroke/TIA, functional change]

Referral Information

Reason for Referral: [Chief cognitive or functional concern prompting referral, who requested the evaluation, and what clinical decisions it will inform] (If the referral question was vague, document the working questions addressed and note this limitation.)

Referral Questions Addressed: [Cognitive staging / Etiologic clarification / Functional safety planning / Caregiver guidance / Capacity-related considerations]

Sources of Information:

• Patient interview: [date]
• Informant interview: [name, relationship, date] (If no informant available, explicitly state: "No informant available—limits functional staging confidence.")
• Medical records reviewed: [Neurology notes, imaging reports, labs, prior cognitive screens, prior neuropsych testing, medication list—specify types and dates]

Background and History

Presenting Concerns and Course: [Onset, tempo (insidious / stepwise / fluctuating), progression, and cognitive domains affected] (Attribute each element to source: patient report, informant report, or medical record.)

Functional Status: Basic ADLs (bathing, dressing, toileting, feeding): [Level of independence]. IADLs (finances, medication management, appointments, shopping, cooking, driving, household tasks): [Level of independence for each]. Current living situation: [Living arrangement and supervision level]. (Attribute to patient, informant, or record.)

Safety Considerations: Driving: [Accidents, citations, getting lost, near misses, caregiver concerns, current status]. Medication management: [Errors, missed doses, concerns]. Finances: [Vulnerability, errors, exploitation concerns]. Home safety: [Kitchen safety, falls, wandering risk]. (For driving, medications, and finances, state "Not assessed" if not evaluated rather than omitting.)

Medical History: [Vascular risk factors, head injury, neurological conditions, movement symptoms, gait changes, sensory impairments affecting testing, other relevant comorbidities]

Medications and Substances: [Current medications with attention to anticholinergic burden and sedating agents; recent medication changes; alcohol and substance use]

Neuropsychiatric Symptoms: [Depression, anxiety, apathy, irritability, psychotic symptoms, sleep disturbance including REM sleep behavior disorder symptoms if suspected]

Developmental and Occupational Background: [Highest education level and quality, occupational complexity, primary language, history of learning difficulties] (Use to support premorbid ability estimation and norm selection.)

Family History: [Dementia, movement disorders, psychiatric illness; note age of onset if early-onset presentations]

Prior Cognitive Data: [Prior screening scores (MoCA, MMSE) with dates; prior neuropsychological testing results for comparison]

Behavioral Observations

[Appearance, engagement, rapport, speech and language characteristics, affect and mood, insight and anosognosia, motor findings, use of sensory aids]. [Test-taking behaviors: effort, frustration tolerance, fatigue effects, response to cues and repetition]. (Include direct patient quotes only when illustrating clinically meaningful insight or safety beliefs.)

Procedures and Validity

Measures Administered: (Group by domain; include test versions for longitudinal tracking.)

• Attention/Executive: [Tests and versions]
• Learning and Memory: [Verbal tests]; [Visual tests]
• Language: [Tests]
• Visuospatial: [Tests]
• Processing Speed: [Tests]
• Mood/Behavioral Questionnaires: [Scales]
• Functional Scales: [Instruments]

Validity Assessment: [Performance validity measures and/or embedded indicators used; outcomes]. [Clinically relevant confounds (sensory deficits, language barriers, fatigue, pain, poor sleep) and impact on interpretability]. (Link validity conclusions to interpretive confidence in formulation.)

Normative Standards: [Norm sets used; demographic corrections applied]. [Limitations when norms are not well matched for language, culture, or education].

Results

Cognitive Profile Summary: Estimated premorbid ability: [Method and estimated range]. Overall pattern: [Strengths and weaknesses across domains]. Memory profile: [Encoding vs retrieval deficit, rapid forgetting, recognition pattern, cueing benefit].

Qualitative Descriptors: [Define descriptor-to-percentile mapping (e.g., Average = 25th–75th %ile, Low Average = 9th–24th %ile, Borderline = 2nd–8th %ile, Impaired = <2nd %ile)] (State mapping once and apply consistently.)

• Attention/Working Memory: [Tests] — [Standardized scores and percentiles] — [Qualitative descriptor] — [Clinical interpretation and daily function implications]
• Processing Speed: [Tests] — [Scores and percentiles] — [Descriptor] — [Implications]
• Executive Functions: [Set-shifting, inhibition, problem-solving, fluency tests] — [Scores and percentiles] — [Descriptor] — [Implications]
• Learning and Memory (Verbal): [Acquisition rate, delayed recall, recognition, cueing] — [Scores and percentiles] — [Descriptor] — [Interpretation]
• Learning and Memory (Visual): [Immediate and delayed recall, recognition] — [Scores and percentiles] — [Descriptor] — [Interpretation]
• Language: [Naming, fluency, comprehension, repetition] — [Scores and percentiles] — [Descriptor] — [Interpretation]
• Visuospatial Abilities: [Construction, perception] — [Scores and percentiles] — [Descriptor] — [Interpretation]
• Mood/Behavioral Measures: [Scores and interpretation] — [Implications for cognition and function]
• Functional Scales: [Scores and interpretation] — [Implications for safety and independence]

(Omit domains not assessed unless absence materially limits interpretation, in which case note: "[Domain]: Not assessed—limitation.")

Integrated Formulation

Etiologic Considerations: [Synthesis of history, functional data, behavioral observations, cognitive pattern, and validity]. Most likely etiology: [Diagnosis and supporting features]. Alternatives: [Diagnoses considered and what would strengthen or weaken each]. [Mixed pathology considerations if applicable]. Potentially reversible contributors: [Depression, sleep disorders, medications, metabolic factors, sensory impairment]. [Integration of available biomarkers and imaging]. (If additional workup would change management, recommend specific studies.)

Functional Implications: [What the cognitive pattern means for current safety and independence]. [Anticipated trajectory using cautious, conditional language]. [Whether this evaluation establishes a baseline for monitoring]. (Do not assign dementia severity without documented functional impairment from patient and/or informant.)

Diagnoses

• Primary: [Diagnosis, ICD-10 code, severity specifier, etiology]
• Comorbid: [Neuropsychiatric diagnoses with ICD-10 codes]
• Rule out: [Conditions under consideration]

(Diagnostic labels must match evidence presented in staging and functional assessment sections.)

Recommendations

Safety and Risk Mitigation

• Driving: [Restriction and/or referral for formal driving evaluation; transportation alternatives] — Who: [Party] — Rationale: [Finding-based]
• Medication management: [Supports such as pill organizer, automated dispenser, pharmacy blister packs] — Who: [Party] — Rationale: [Finding-based]
• Financial protections: [POA planning, trusted contact, bank alerts, bill pay automation] — Who: [Party] — Rationale: [Finding-based]
• Home safety: [Stove/oven safeguards, fall prevention, wandering prevention] — Who: [Party] — Rationale: [Finding-based]
• Supervision and emergency planning: [Recommendations] — Who: [Party] — Rationale: [Finding-based]

Medical Follow-Up

• Medication review: [Review cognitive-impairing medications and anticholinergic burden] — Who: [Prescriber or pharmacist] — Rationale: [Finding-based]
• Treat comorbidities: [Sleep apnea, depression, hearing/vision loss, vascular risks] — Who: [Clinician or service] — Rationale: [Finding-based]
• Additional workup: [Labs, neuroimaging, biomarkers, sleep study, EEG as indicated] — Who: [Clinician or service] — Rationale: [How results would change management]
• Specialty referrals: [Neurology, Geriatrics, Memory Clinic, Psychiatry, OT, SLP] — Who: [Referring clinician] — Rationale: [Finding-based]

Cognitive and Functional Interventions

• Compensatory strategies: [External memory systems, routines, environmental modifications] — Who: [Patient, caregiver, OT, SLP] — Rationale: [Target deficits]
• Rehabilitation referrals: [OT for IADLs and safety; SLP for memory and communication strategies] — Who: [Service] — Rationale: [Target deficits]

Caregiver Support

• Education: [Cognitive profile explanation and communication strategies] — Who: [Clinician or care team] — Rationale: [Promote safety and quality of life]
• Caregiver resources: [Stress screening, respite resources, support groups] — Who: [Care team or social work] — Rationale: [Reduce caregiver burden]
• Red flags for urgent reassessment: [Safety events, rapid decline, new hallucinations or delusions, stroke/TIA symptoms] — Who: [Patient and caregiver awareness]

Follow-Up Plan

• Re-evaluation interval: [Timeframe] — Medical necessity: [Baseline establishment, monitoring progression, treatment response, decision-making support]
• Earlier reassessment triggers: [Safety events, medical changes, rapid functional decline]

Limitations

• [Missing records or limited informant data] — Impact: [Effect on confidence]
• [Language or cultural factors and norm mismatch] — Impact: [Effect on confidence]
• [Sensory impairments] — Impact: [Effect on confidence]
• [Fatigue, pain, mood interference, poor sleep] — Impact: [Effect on confidence]
• [Validity concerns] — Impact: [Effect on interpretation and staging]

(If limitations materially affect diagnostic certainty, explicitly state the reduced confidence level. Omit limitation categories that do not apply.)

Feedback Session

Date: [Feedback date] Participants: [Patient; family members or care partners present]. Key education points: [Summary of information provided]. Understanding and response: [Patient and family comprehension and emotional response]. Next steps confirmed: [Actions and responsible parties]. (If feedback has not yet occurred, document: "Feedback session scheduled for [date]" or "Feedback to be provided by [method].")

Signature

[Examiner Name, Degree, Credentials]
License Number: [License number]
Institution: [Institution name]
Contact Information: [Phone and/or email]
Signature and Date: _____________________________ Date: __________